Skip to main content
. 2018 Jun 5;15(6):1179. doi: 10.3390/ijerph15061179

Table 1.

Participant characteristics by race/ethnicity.

No. of Participants Total Non-Hispanic White African American Hispanic Chinese American p-Value
264 84 56 65 59
Age (SD) 61.5 (9.7) 61.3 (10.4) 62.4 (9.1) 60.7 (8.7) 61.9 (10.2) 0.78
Male (%) 149 (56.4) 44 (52.4) 24 (42.9) 39 (60.0) 42 (71.2) 0.02
BMI (SD) 27.5 (5.4) 27.1 (4.9) 29.4 (5.6) 29.7 (5.1) 24.0 (3.9) <0.01
Study site (%): <0.01
Winston-Salem, NC 28 (10.6) 15 (17.9) 13 (23.2) 0 (0.0) 0 (0.0)
New York City, NY 44 (16.7) 13 (15.5) 10 (17.9) 21 (32.3) 0 (0.0)
Baltimore, MD 23 (8.7) 14 (16.7) 9 (16.1) 0 (0.0) 0 (0.0)
St Paul, MN 35 (13.3) 13 (15.5) 0 (0.0) 22 (33.8) 0 (0.0)
Chicago, IL 48 (18.2) 14 (16.7) 10 (17.9) 0 (0.0) 24 (40.7)
Los Angeles, CA 86 (32.6) 15 (17.9) 14 (25.0) 22 (33.8) 35 (59.3)
iAs% (IQR) 1 4.2 (2.0, 6.7) 4.4 (2.4, 6.5) 3.5 (2.0, 5.8) 3.6 (1.9, 6.5) 5.1 (2.2–8.2) 0.60
MMA% (IQR) 1 10.3 (6.5, 14.9) 9.8 (5.6, 14.4) 12.0 (7.6, 16.0) 8.8 (5.9, 13.2) 10.7 (7.3–15.5) 0.14
DMA% (IQR) 1 85.5 (79.2, 89.8) 85.9 (79.4, 90.3) 83.6 (79.2, 86.9) 86.6 (80.9, 91.2) 85.2 (76.1, 89.5) 0.15
Sum of iAs, MMA, DMA (IQR) 1 3.2 (1.9, 5.5) 2.3 (1.5, 4.2) 2.6 (1.6, 4.3) 3.8 (2.4, 6.1) 4.9 (2.9, 7.1) <0.01
Total Ab (IQR) 1 4.7 (1.0, 18.1) 5.4 (1.2, 17.9) 3.4 (1.0, 16.8) 4.7 (1.0, 18.4) 5.7 (1.1, 25.0) 0.90
PC1 (IQR) 1 1.9 (−5.8, 7.4) 2.5 (−6.4, 8.0) −0.4 (−5.8, 3.8) 2.8 (−3.7, 8.9) 0.8 (−9.5, 7.0) 0.15
PC2 (IQR) 1 0.3 (−2.3, 2.7) 0.1 (−2.4, 2.5) 0.8 (−1.6, 3.2) 0.1 (−2.8, 2.5) −0.1 (−2.5, 1.9) 0.47

Results presented as mean (SD), or median (IQR); SD, standard deviation; BMI, body mass index; IQR, interquartile range; iAs, inorganic arsenic; MMA, monomethylarsonate; DMA, dimethylarsinate; Ab, arsenobetaine; PC1, principal components 1; PC2, principal components 2. 1 All arsenic species and sum estimates are adjusted for arsenobetaine.